AzTrials
AzTrials

Edentulous Alveolar RidgeEarly Phase 1MSC&IMPLANTSNCT02731586

Effect on Allogenic Mesenchymal Stem Cells on Osseointegration of Dental Implants

A Early Phase 1 study testing Allogenic Mesenchymal stem cells in people with Edentulous Alveolar Ridge, run by Sri Sai College of Dental Surgery and Research Centre at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

As Regenerative Medicine is the next level in medicinal sciences, the use of mesenchymal cells have become prevalent, Similarly now stem cells are being used in dental research as well in various clinical applications.This study aims to evaluate the overall effect of osseointegration by use of Allogenic Mesenchymal… Read more about this study

Who is it for?
Ages 18 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Edentulous Alveolar Ridge
What is being tested?
Allogenic Mesenchymal stem cells
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteIndia
Study dates
Jan 2016to Mar 2018
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with bilateral edentulous condition either partial or complete.
  • Patients maintaining adequate oral hygiene
  • Patients with dimensions of alveolar jaw bone in Occlusso-Gingival position >10mm and Bucco-Lingual position < 6mm.

Who cannot join

  • Systemic diseases which are likely to compromise Implant surgery like Diabetes Mellitus Type I, II and Osteoporosis.
  • Patients with oral parafunctional habits like Bruxism.
  • Smokers who smoke more than 10 cigarettes a day.
  • Self-declared pregnancy or intention to become Pregnant.
  • The use of Regenerative procedures in conjunction with Implant placement.Eg- Grafts ,Sinus Lift procedures.

Trial locations and contacts

1 site in 1 country.

India1 site
  • Sri Sai College Of Dental Surgery and Research Centre

    Vikārābād, Telangana State, 501101

Other trials in India

About this study

Official title: Comparative Clinical Evaluation of Osseointegration of Dental Implants Placed With and Without, the Use of Dental Pulp-derived Allogenic Mesenchymal Stem Cells.

As Regenerative Medicine is the next level in medicinal sciences, the use of mesenchymal cells have become prevalent, Similarly now stem cells are being used in dental research as well in various clinical applications.This study aims to evaluate the overall effect of osseointegration by use of Allogenic Mesenchymal Stem cells while placing dental implants.Healthy subjects will be chosen and dental implants placed bilaterally one with standard surgical protocol and other with the use of Allogenic Mesenchymal Stem cells.The implant stability is checked using Resonance frequency analysis(RFA).The RFA values are statistically evaluated at various intervals and observations will be analysed on both test and control side.

Read the detailed description

This study prospective single center study . A total of 10 patients are selected to be treated with dental implants for their bilaterally missing edentulous condition, which can be supported by either removable or fixed rehabilitation. The edentulous space can either be in maxilla or mandible. The study is performed at the Department of Implantology (Sri Sai College Of Dental Surgery and Research Center, Vikarabad, India). The study is approved by institutional ethics committee (IEC).

MATERIAL AND METHODS

  1. Nobel Biocare Replace Select Dental Implants of size 4.3x10 mm. Healing abutments and implant abutments. 20 Numbers.
  2. Nobel Biocare surgical kit
  3. Nobel Biocare physio dispenser
  4. Transchymal Dental pulp derived Allogenic mesenchymal cells.
  5. Ostell ISQ device along with a Smart peg.
  6. A Centrifuge.
  7. Sterile centrifuge tubes,
  8. Sterile pipettes
  9. Bone roungers
  10. IOPA and KKD Radiographic system
  11. Cold saline
  12. Suture material and suture needles
  13. 70% isopropanol
  14. Chiller and a Thermo cool box to carry dry ice
  15. Sterile cotton and gauze
  16. Mouth mirror
  17. Dental examination Probe
  18. Needle holder
  19. Artery Forceps and scissors.
  20. Surgical gown,patient drape, Mouth mask, head cap and surgical gloves
  21. High power suction and suction tips.
  22. Betadine and chlorhexidine mouthwash.
  23. BP blade handle and BP blade no 11,12 and 15
  24. Canon DSLR camera
  25. Patient models and surgical guide
  26. Informed and written consent forms.
  27. Case history records
  28. Photography and videography waiver consent form
  29. Ethical Clearance Certificate
  30. CBCT
  31. Vital parameters data sheet
  32. Diagnostic reports of CBP, RBS, CT, BT and Hg%
  33. Antibiotic and anti-allergic prophylaxis.
  34. A local anesthetic solution containing 2% lignocaine with 1:100,000-epinephrine and 2ml disposable syringe.
  35. Statistical analysis software IBM SPSS version 19.

METHODS

Clinical Procedure

Pre-operative planning is based on clinical and radiographic examination. After thoroughly recording the case history. The following investigations will be done prior to implant placement surgery: CBCT, CBP, CT, BT, Hg%, RBS, Vital signs and other relevant investigations. If all the parameters fulfill the inclusion and exclusion criteria, the patient's impressions are made and study models poured. Intraoral and extraoral photographs are taken. The surgical guide is constructed on the diagnostic models.Stem cells are carried from stem cell bank to the Department of Implantology in a cryovial, safely placed in the special device, which contains dry ice, to maintain the viability of stem cells.

Surgical Procedure

On the day of surgery, the dental operatory is thoroughly fumigated and all the infection control protocols are followed.The participants will be receiving oral and written information about the study and shall be providing the informed consent along with photography and videography waiver consent. Antimicrobial prophylaxis (amoxicillin 1gm) and antihistamine prophylaxis (20mg cetirizine) orally 1 hour before surgery should be given to the patient. The universal precautions protocol is followed to protect yourself, the patients and the dental assistant.The patient is asked to rinse the Oral cavity with chlorhexidine gluconate solution (0.2%) for 1 minute before surgery.

IMPLANT PLACEMENT ON THE CONTROL SIDE

To standardized the protocol the patient's right side is selected as the control side and left side as the test side. The surgical procedure is carried out under local anesthesia containing 2% epinephrine with 1:100,000 epinephrine. The surgical guide is placed on the teeth and is used to mark the position of the implant with round drill till it hits the bone. Mucoperiosteal flaps were raised with mid crestal incision and intrasulcular incision extending to one tooth mesially and other teeth distally. After full thickness flap elevation, the osteotomy sites are prepared using the drilling sequence instructed by the manufacturer.The dental implants Nobel Biocare Replace select (4.3 *10mm size) 4.3mm diameter and 10mm length is selected and placed in the osteotomy site with IF of 40 Ncm.Before approximation of the flap, the primary stability of the implant is recorded with the ostell device, which has a transducer attached to the device and a magnetic attachment smart peg is attached to the implant with a plastic peg holder each implant is measured twice from two different angles,around 90 degrees and parallel to the crestal line.The two measurements buccolingually and mesiodistally are recorded and an average of both the values are taken.The measurements values are then transferred into implant stability quotient (ISQ) units, which are given on a scale of 1- 100, with 100 being the highest degree of stability and it works on the principle of resonance frequency analysis (RFA).The smart peg is removed and Healing abutments are placed over the dental implants. The flap is sutured monofilament sutures 4-0. IOPAR are taken with KKD Radiograph system, which standardizes the distance between the collimator and the IOPAR.

IMPLANT PLACEMENT ON THE TEST SIDE

To standardized the protocol the patient's left side is chosen as the test side.The surgical procedure is carried out under local anesthesia containing 2% epinephrine with 1:100,000 epinephrine. The surgical guide is placed on the teeth and is used to mark the position of the implant with round drill till it hits the bone. Mucoperiosteal flaps were raised with mid crestal incision and intrasulcular incision extending to one tooth mesially and another tooth distally. After full thickness flap elevation, the osteotomy sites are prepared using the drilling sequence instructed by the manufacturer. the stem cells are centrifuged in a sterile environment as per the instructions are given by the stem cell bank.(Thawing protocol )Human mesenchymal stem cells (hMSC) are primary cells which can be successfully used for infusion purpose.The following is the recommended protocol for thawing and infusion of these cells:Remove the Cryovial of stem cells from dry ice,defrost the vial containing stem cells by placing in between both the palms with constant, moderate agitation, until ice in the ampule is no longer visible,immediately disinfect the vial with 70% isopropanol.Working under laminar flow hood, open the vial and transfer the contents to a sterile 15ml centrifuge tube and centrifuge at 3500 RPM for 5 minutes. Decant the supernatant and to the pellet add 1 ml of saline.Mix properly and the cells are ready for infusion at the osteotomy site. Remove the contents in a sterile dappen dish and before infusion of stem cells at the osteotomy site the implant is dipped in the solution for 3 minutes so that the stem cells adhere to the titanium implant surface. The same dental surgeon performs all the cases. The dental implants Nobel Biocare Replace select (4.3 *10mm size) 4.3mm diameter and 10mm length is selected and placed in the osteotomy site with IF of 40 Ncm11.Before approximation of the flap, the primary stability of the implant is recorded with the ostell device, which has a transducer attached to the device and a magnetic attachment smart peg is attached to the implant with a plastic peg holder each implant is measured twice from two different angles,around 90 degrees and parallel to the crestal line.The two measurements buccolingually and mesiodistally are recorded and an average of both the values are taken.The measurements values are then transferred into implant stability quotient (ISQ) units, which are given on a scale of 1- 100, with 100 being the highest degree of stability and it works on the principle of resonance frequency analysis (RFA).The smart peg is removed and Healing abutments are placed over the dental implants. The flap is sutured monofilament sutures 4-0.IOPAR are taken with KKD radiograph system, which standardizes the distance between the collimator and the IOPAR.

POST SURGICAL TREATMENT

The patient is advised to take soft diet for one week and not to spit and rinse for the next 24 hours. Antibiotics, Antihistamines, and NSAIDs must be continued for 3 days. Postoperative edema if any must be controlled with corticosteroids. The sutures are removed one week postoperatively.

Recall visits

Weekly recall of the patient for 12 weeks for evaluation and recording of implant stability measurements with Ostell ISQ device. Patient safety measures are evaluated on every visit like unusual pain, swelling, allergic reaction, inflammation, outgrowth, vital signs, blood assay or any unspecific reactions should be noted down. The emergency contact number is provided to the patient to report any abnormal incidence immediately. The prosthetic part of the treatment is to be carried out after 3 months either with removable or fixed rehabilitation.

Statistical analysis

Descriptive statistics will be computed to summarize the data for its central tendency and dispersion. Two sample t-test will be applied to see the mean change in the outcome variable between experimental and control groups. Repeated measures of ANOVA are being applied to see the time changes between experimental and control groups. Where ever data is not following uniformity, either transforming the data or nonparametric statistical technique will be applied. The analysis will be performed using IBM SPSS Version 19.0.

Being tested
Allogenic Mesenchymal stem cells
Keywords
Dental Implants, Allogenic mesenchymal stem cells, osseointegration, primary stability, resonance frequency analysis, RFA, implants and stem cells, use of stem cells, stem cells

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Allogenic Mesenchymal stem cellsDrug

    Also called Transchymal

    Allogenic mesenchymal stem cells are introduced during placement of dental implants.

Study groups in NCT02731586
Study groupRoleWhat they receive
osseointegration using Allogenic MSC'sExperimentalEvaluation of Osseointegration of Dental Implants to be done using Allogenic Mesenchymal Stem Cells.Primary and Secondary stability are measured using RFA.
Receives: Drug: Allogenic Mesenchymal stem cells

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determination of Implant Stability with RFA

    Dental Implant stability is a measure of primary stability and secondary stability.The Implant stability can be perceived as a combination of Mechanical stability, which is the result of compressed bone holding the implant tightly in place (Primary Stability) and biological stability, which is the result of new bone cells forming at the site of the implant and resultant osseointegration(Secondary stability).The Implant Stability Quotient (ISQ) is a scale of measurement developed by Osstell device for use with the Resonance Frequency Analysis (RFA) method of measuring implant stability. The Implant Stability Quotient is a linear mapping from resonance frequency measured in kHz to the more clinically useful scale of 1-100 ISQ. The higher the ISQ, the more stable is the implant. The Implant stability is measured every fortnight for three months in 10 patients.The values on test side and control side are plotted on the graph and analysed.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2016 (estimated)
  2. Study startJan 2016
  3. Primary completionDec 2017 (estimated)
  4. Study completionMar 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02731586
Sponsor's protocol ID
SSCDS-IMP-201601
Acronym
MSC&IMPLANTS
Status last verified
Oct 2017
First submitted
3 Apr 2016
Last updated
6 Oct 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided: upon total enrollment of participants, it shall be decided.

Publications

  • Haniffa MA, Collin MP, Buckley CD, Dazzi F. Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica. 2009 Feb;94(2):258-63. doi: 10.3324/haematol.13699. Epub 2008 Dec 23.

    PubMed 19109217
  • Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008 Sep;8(9):726-36. doi: 10.1038/nri2395.

    PubMed 19172693
  • Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003 Oct;31(10):890-6. doi: 10.1016/s0301-472x(03)00110-3.

    PubMed 14550804
  • Meredith N. Assessment of implant stability as a prognostic determinant. Int J Prosthodont. 1998 Sep-Oct;11(5):491-501.

    PubMed 9922740
  • Lavenus S, Berreur M, Trichet V, Pilet P, Louarn G, Layrolle P. Adhesion and osteogenic differentiation of human mesenchymal stem cells on titanium nanopores. Eur Cell Mater. 2011 Aug 26;22:84-96; discussion 96. doi: 10.22203/ecm.v022a07.

    PubMed 21870339
  • Limet R. [Advantages of side-to-side anastomosis in coronary surgery[(author's transl)]]. Acta Chir Belg. 1976 Jul;75(4):390-401. French.

    PubMed 1087820

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Allogenic Mesenchymal stem cells in people with Edentulous Alveolar Ridge, run by Sri Sai College of Dental Surgery and Research Centre at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determination of Implant Stability with RFA (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02731586, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in